Category: Treatment
The EU pays more than 1 billion euros for Remdesivir
The European Union has agreed to pay more than 1 billion euros to Gilead for a six-month supply of its antiviral drug remdesivir, shortly before the publication of final results of the biggest trial of the COVID-19 medication. More...